Patents by Inventor Sudhirdas Prayaga

Sudhirdas Prayaga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060094647
    Abstract: The present invention is based upon methods of treating inflammatory conditions in the intestinal tract of mammals using growth factor related polypeptides. Methods of using fibroblast growth factor-CX (FGF-CX) polynucleotide sequences and the FGF-CX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, are claimed in the invention. Similarly, methods of using FCTRX polynucleotide sequences and the FCTRX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, alone or in combination, are also claimed in the invention. FCTRX collectively refers to any of six variant FCTRX sequences, variously designated FCTR1, FCTR2, FCTR3, FCTR4, FCTR5 and FCTR6.
    Type: Application
    Filed: November 6, 2001
    Publication date: May 4, 2006
    Inventors: Michael Jeffers, Richard Shimkets, Sudhirdas Prayaga, Ferenc Boldog, Meijia Yang, Catherine Burgess, Elma Fernandes, Beth Rittman, Juliette Shimkets, William LaRochelle, Henri Lichenstein
  • Publication number: 20050287564
    Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: May 10, 2005
    Publication date: December 29, 2005
    Inventors: Linda Gorman, Richard Shimkets, Carol Pena, Valerie Gerlach, Kumud Majumder, Sudhirdas Prayaga, Catherine Burgess
  • Publication number: 20050208514
    Abstract: The present invention generally relates to nucleic acids, proteins, and antibodies. The invention relates more particularly to nucleic acid molecules, proteins, and antibodies of Fibroblast Growth Factor-20 (FGF-20), or its fragments, derivatives, variants, homologs, analogs, or a combination thereof.
    Type: Application
    Filed: November 3, 2004
    Publication date: September 22, 2005
    Inventors: John Alsobrook, Ferenc Boldog, Michael Jeffers, William LaRochelle, Denise Lepley, Henri Lichenstein, Richard Shimkets, Meijia Yang, Marie Ruiz-Martinez, Galina Chernaya, Muralidhara Padigaru, Sudhirdas Prayaga, Mei Zhong
  • Publication number: 20050208540
    Abstract: The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states,as well as to other uses.
    Type: Application
    Filed: December 30, 2004
    Publication date: September 22, 2005
    Applicant: CuraGen Corporation
    Inventors: Richard Shimkets, Sudhirdas Prayaga
  • Publication number: 20050063971
    Abstract: The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as other uses.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 24, 2005
    Inventors: Michael Jeffers, Richard Shimkets, Sudhirdas Prayaga, Ferenc Boldog, Meijia Yang, Catherine Burgess, Elma Fernandes, John Herrmann, William LaRochelle, Henri Lichenstein
  • Publication number: 20050053930
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: June 3, 2003
    Publication date: March 10, 2005
    Inventors: David Anderson, Ferenc Boldog, Catherine Burgess, Stacie Casman, Shlomit Edinger, Andrew Eisen, Karen Ellerman, Valerie Gerlach, Linda Gorman, Xiaojia Guo, Vladimir Gusev, Weizhen Ji, Li Li, John MacDougall, Uriel Malyankar, Isabelle Millet, Tatiana Ort, Muralidhara Padigaru, Sudhirdas Prayaga, Meera Patturajan, Carol Pena, John Peyman, Daniel Rieger, Mark Rothenberg, Paul Sciore, Suresh Shenoy, Glennda Smithson, Kimberly Spytek, David Stone, Raymond Taupier, Velizar Tchernev, Corine Vernet, Edward Voss, Bryan Zerhusen, Mei Zhong
  • Publication number: 20050003370
    Abstract: Disclosed herein are novel human nucleic acid sequences. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving these novel nucleic acids and proteins.
    Type: Application
    Filed: September 7, 2004
    Publication date: January 6, 2005
    Inventors: Sudhirdas Prayaga, Raymond Taupier, Raj Bandaru
  • Publication number: 20020065405
    Abstract: The present invention provides novel isolated NOVX polynucleotides and polypeptides encoded by the NOVX polynucleotides. Also provided are the antibodies that immunospecifically bind to a NOVX polypeptide or any derivative, variant, mutant or fragment of the NOVX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the NOVX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: January 16, 2001
    Publication date: May 30, 2002
    Inventors: Muralidhara Padigaru, Sudhirdas Prayaga, Raymond J. Taupier, Vishnu Mishra, Velizar Tchernev, Kimberly Spytek, Li Li